See more : Royal Olympic Cruise Lines, Inc. (ROCLF) Income Statement Analysis – Financial Results
Complete financial analysis of TRANSNATIONAL CANNABIS LTD (TRCNF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TRANSNATIONAL CANNABIS LTD, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Kaneka Corporation (KANKF) Income Statement Analysis – Financial Results
- W.I.S.E. – CSI HK 100 Tracker (2825.HK) Income Statement Analysis – Financial Results
- BTS Group Holdings Public Company Limited (BTS.BK) Income Statement Analysis – Financial Results
- BrightStar Information Technology Group, Inc. (BTSR) Income Statement Analysis – Financial Results
- Rego Interactive Co., Ltd (2422.HK) Income Statement Analysis – Financial Results
TRANSNATIONAL CANNABIS LTD (TRCNF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.intlcannabiscorp.com
About TRANSNATIONAL CANNABIS LTD
TRANSNATIONAL CANNABIS LTD, through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and transport cannabis and derivative products; and engages in procuring and distributing medical cannabis products and cannabis derivatives. The company has strategic partnerships with Green Tree International Inc., Auxly Cananbis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. The company was formerly known as ICC International Cannabis Corp. and changed its name to TRANSNATIONAL CANNABIS LTD in February 2020. TRANSNATIONAL CANNABIS LTD was incorporated in 2006 and is headquartered in Vancouver, Canada.
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 51.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 35.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 16.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 31.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 4.69M | 0.00 | 0.00 | 67.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 36.47M | 978.17K | 392.57K | 278.64K | 446.47K | 107.06K | 207.93K | 334.14K | 385.03K | 166.01K | 89.09K | 86.38K |
| Selling & Marketing | 0.00 | 0.00 | 2.40K | 26.61K | 98.52K | 1.07K | 4.96K | 6.52K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.47M | 978.17K | 394.97K | 305.25K | 544.99K | 108.13K | 212.89K | 340.65K | 385.03K | 166.01K | 89.09K | 86.38K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.11K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 41.51M | 978.17K | 394.97K | 305.25K | 544.99K | 113.06K | 253.78K | 340.65K | 432.68K | 166.01K | 89.09K | 86.38K |
| Cost & Expenses | 41.51M | 978.17K | 394.97K | 340.33K | 544.99K | 113.06K | 253.78K | 340.65K | 432.68K | 166.01K | 89.09K | 86.38K |
| Interest Income | 19.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 391.02K | 13.16K | 1.76K | 972.00 | 940.00 | 747.00 | 455.00 | 740.00 | 1.22K | 2.09K | 57.21K | 95.00 |
| Depreciation & Amortization | 171.86K | 161.14K | 1.76K | 972.00 | 940.00 | 747.00 | 3.61K | 3.74K | 150.67K | 2.09K | 57.21K | 95.00 |
| EBITDA | -41.49M | -41.49M | -394.97K | -394.97K | -288.77K | -497.70K | -113.06K | -250.63K | -283.23K | -166.01K | -89.09K | -86.38K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -560.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -41.49M | -978.17K | -396.73K | -289.74K | -545.93K | -113.81K | -254.24K | -341.39K | -433.90K | -168.10K | -146.30K | -86.48K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -561.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -18.82M | 39.78M | 175.14K | -381.17K | 54.43K | -47.75K | -37.00 | -944.00 | -241.95K | -149.45K | -176.35K | -236.17K |
| Income Before Tax | -60.31M | -988.90K | -777.90K | -298.89K | -551.21K | -113.85K | -255.18K | -348.50K | -583.35K | 0.00 | -322.65K | -86.48K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -579.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 219.16K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -60.31M | -988.90K | -777.90K | -298.89K | -551.21K | -113.85K | -255.18K | -348.50K | -583.35K | -168.10K | -322.65K | -86.48K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -579.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.37 | -0.06 | -0.07 | -0.04 | -0.08 | -0.04 | -0.11 | -0.16 | -0.29 | -0.13 | -0.35 | -0.10 |
| EPS Diluted | -0.37 | -0.06 | -0.07 | -0.04 | -0.08 | -0.04 | -0.11 | -0.16 | -0.29 | -0.13 | -0.35 | -0.10 |
| Weighted Avg Shares Out | 164.39M | 16.66M | 11.35M | 8.24M | 7.07M | 2.79M | 2.42M | 2.23M | 1.98M | 1.28M | 925.91K | 863.98K |
| Weighted Avg Shares Out (Dil) | 164.39M | 16.66M | 11.35M | 8.24M | 7.07M | 2.79M | 2.42M | 2.23M | 1.98M | 1.28M | 925.91K | 863.98K |
Source: https://incomestatements.info
Category: Stock Reports